MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

Description

MARKET OUTLOOK

CRI’s report on the cardiovascular ultrasound market in the Middle East and Africa puts forth that it would grow with a CAGR of 6.31% in the forecast period 2022-2028. Saudi Arabia, Turkey, the United Arab Emirates, South Africa, and Rest of Middle East & Africa are scrutinized in the market in this region.
According to estimates, cardiovascular disease (CVD) accounts for nearly 42% of all mortalities in Saudi Arabia. The risk factors for CVD can be classified into two sections: modifiable factors like obesity, hypertension, diabetes, dyslipidemia, and smoking, and non-modifiable factors like ethnicity, age, and family history.
A staggering 55.5% of the Saudi Arabian population is either hypertensive or pre-hypertensive; whereas, 20.2% of the population is diabetic. Awareness of CVD and its risk factors is critical in order to encourage people to adopt a healthier lifestyle. This, in turn, has boosted the use of cardiovascular ultrasound systems in the country, and is expected to drive the market growth in the forthcoming years.
At a mortality rate of 47%, cardiovascular disease accounts for nearly half of all deaths in Turkey. In 2020, close to 85,905 people lost their lives due to coronary heart disease in the country. However, Turkey has also been successful in managing these conditions by increasing the availability of percutaneous cardiac interventions for its citizens. This has promoted the adoption of echocardiography systems. The rising adoption is expected to lead the Turkish market on a growth path.

COMPETITIVE OUTLOOK

The notable players in the cardiovascular ultrasound market include Lanmage, Samsung Medison Co Ltd, Mindray Medical International Limited, Esaote S.p.A., Canon Medical Corp, GE Healthcare, Viatom Technology Co, and Philips Healthcare.

TABLE OF CONTENTS

1. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. PRODUCT LAUNCHES
2.8.2. ALLIANCES
2.9. MARKET DRIVERS
2.9.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.9.2. ADVANCEMENTS IN TECHNOLOGY
2.10. MARKET CHALLENGES
2.10.1. LACK OF AWARENESS AMONG PATIENTS
2.10.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.11. MARKET OPPORTUNITIES
2.11.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.11.2. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED ARAB EMIRATES
7.2. SAUDI ARABIA
7.3. TURKEY
7.4. SOUTH AFRICA
7.5. REST OF MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF PRODUCT LAUNCHES
TABLE 4: LIST OF ALLIANCES
TABLE 5: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED ARAB EMIRATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: SAUDI ARABIA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: TURKEY CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: SOUTH AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: REST OF MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)